Search research articles
Contact Us
Filters
Showing results (101-110 of 349) with videos related to
Page
of 35
Sort By:
Translational and Clinical Pharmacology
|
February 15, 2020
Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment
Sumin Yoon, Sojeong Yi, Su-Jin Rhee, et al.
Drug Design, Development and Therapy
|
August 24, 2019
Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers
Dongseong Shin, Sang-In Park, Hong-Sub Lee, et al.
Clinical Pharmacology in Drug Development
|
August 2, 2021
Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects
Joo Young Na, Inseung Jeon, Jangsoo Yoon, et al.
British Journal of Clinical Pharmacology
|
April 23, 2002
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
Joo-Youn Cho, Kyung-Sang Yu, In-Jin Jang, et al.
Clinical Pharmacology and Therapeutics
|
September 7, 2017
Identification of ω- or (ω-1)-Hydroxylated Medium-Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity
Bora Kim, Jieon Lee, Kwang-Hee Shin, et al.
Clinical Therapeutics
|
November 25, 2010
Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers
Tae-Eun Kim, Kyu-Pyo Kim, Bo-Hyung Kim, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 3, 2003
Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine
Joo Youn Cho, Hyeong Seok Lim, Kyung Sang Yu, et al.
Clinical Therapeutics
|
November 18, 2011
Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers
Namyi Gu, Sojeong Yi, Tae-Eun Kim, et al.
Translational and Clinical Pharmacology
|
February 15, 2020
Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
Inyoung Hwang, Sang-In Park, SeungHwan Lee, et al.
Alimentary Pharmacology & Therapeutics
|
October 28, 2020
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities
Jun Gi Hwang, Inseung Jeon, Sun Ae Park, et al.
Page
of 35
Search research articles
Search
Showing results (101-110 of 349) with videos related to
Sort By:
Page
of 35
Translational and Clinical Pharmacology
|
February 15, 2020
Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment
Sumin Yoon, Sojeong Yi, Su-Jin Rhee, et al.
Drug Design, Development and Therapy
|
August 24, 2019
Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers
Dongseong Shin, Sang-In Park, Hong-Sub Lee, et al.
Clinical Pharmacology in Drug Development
|
August 2, 2021
Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects
Joo Young Na, Inseung Jeon, Jangsoo Yoon, et al.
British Journal of Clinical Pharmacology
|
April 23, 2002
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
Joo-Youn Cho, Kyung-Sang Yu, In-Jin Jang, et al.
Clinical Pharmacology and Therapeutics
|
September 7, 2017
Identification of ω- or (ω-1)-Hydroxylated Medium-Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity
Bora Kim, Jieon Lee, Kwang-Hee Shin, et al.
Clinical Therapeutics
|
November 25, 2010
Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers
Tae-Eun Kim, Kyu-Pyo Kim, Bo-Hyung Kim, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 3, 2003
Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine
Joo Youn Cho, Hyeong Seok Lim, Kyung Sang Yu, et al.
Clinical Therapeutics
|
November 18, 2011
Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers
Namyi Gu, Sojeong Yi, Tae-Eun Kim, et al.
Translational and Clinical Pharmacology
|
February 15, 2020
Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
Inyoung Hwang, Sang-In Park, SeungHwan Lee, et al.
Alimentary Pharmacology & Therapeutics
|
October 28, 2020
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities
Jun Gi Hwang, Inseung Jeon, Sun Ae Park, et al.
Page
of 35